Pharmacological management of severe Cushing’s syndrome: the role of etomidate

Cushing’s syndrome (CS) is an endocrine disease characterized by excessive adrenocortical steroid production. One of the mainstay pharmacological treatments for CS are steroidogenesis enzyme inhibitors, including the antifungal agent ketoconazole along with metyrapone, mitotane, and aminoglutethimid...

Descripción completa

Detalles Bibliográficos
Autores principales: Pence, Andrea, McGrath, Megan, Lee, Stephanie L., Raines, Douglas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848075/
https://www.ncbi.nlm.nih.gov/pubmed/35186251
http://dx.doi.org/10.1177/20420188211058583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848075/
https://www.ncbi.nlm.nih.gov/pubmed/35186251
http://dx.doi.org/10.1177/20420188211058583

Ejemplares similares